Skip to main content
Erschienen in: Critical Care 1/2020

Open Access 18.05.2020 | COVID-19 | Research Letter

Advanced respiratory monitoring in COVID-19 patients: use less PEEP!

verfasst von: Lisanne Roesthuis, Maarten van den Berg, Hans van der Hoeven

Erschienen in: Critical Care | Ausgabe 1/2020

Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ARDS
Acute respiratory distress syndrome
COVID-19
Coronary virus disease 2019
PACO2
Partial pressure of carbon dioxide in alveolar air
PaCO2
Partial pressure of carbon dioxide in arterial blood
PeCO2
Partial pressure of carbon dioxide in mixed expired air
PEEP
Positive end-expiratory pressure
SEM
Standard error of the mean
To the Editor,
In the majority of coronavirus disease 2019 (COVID-19) patients, respiratory mechanics is different from the “normal” acute respiratory distress syndrome (ARDS) patient. Plateau pressures and driving pressures are often low and respiratory system compliance relatively normal compared to the ARDS patient [1]. Many physicians use high positive end-expiratory pressure (PEEP) for patients with COVID-19 although the potential for recruitment is often low [1, 2]. We fear that the high compliance of the respiratory system in combination with high PEEP will lead to hyperinflation, high dead space, and potentially right ventricular failure.
We have used the following strategy for COVID-19 patients (N = 70): after intubation, immediately prone positioning for at least 3 days, using the lowest possible PEEP to obtain adequate oxygenation with FiO2 of 50%. We assessed the effects of different PEEP levels on respiratory mechanics and ventilation-perfusion mismatching.

Methods

Respiratory mechanics was assessed in COVID-19 patients admitted to the Radboud University Nijmegen Medical Center as part of standard patient care. Brief occlusions were performed to assess end-inspiratory and end-expiratory airway and transpulmonary pressures (absolute and elastance ratio method) and to calculate respiratory and lung compliances as previously described [3, 4]. Dead space ventilation was assessed using two methods:
1)
The Bohr equation using partial pressure of carbon dioxide in alveolar air (PACO2) and mixed expired air (PeCO2): (PACO2 − PeCO2)/PACO2. See our previous work for detailed description [5].
 
2)
The Enghoff modification of Bohr’s equation using partial pressure of carbon dioxide in arterial blood (PaCO2): (PaCO2 − PeCO2)/PaCO2. Therefore, shunt and diffusion limitations are taken into the equation.
 

Results

Advanced respiratory mechanics was assessed in 14 patients (8 males and 6 females, age (mean ± SEM) 67 ± 2 years, body mass index 28.0 ± 0.9 kg/m2) between the 19th of March and 2nd of April (Table 1). Compliance of the respiratory system was low (42 ± 3 mL/cmH2O) due to a lower than normal lung compliance (61 ± 5 mL/cmH2O). However, compared to ARDS patients, lung compliance was relatively high, resulting in low end-inspiratory transpulmonary pressures (12 ± 1 cmH2O). Chest wall compliance was slightly lower than normal due to prone positioning in most patients. COVID-19 patients had high dead space ventilation and gas exchange impairment (Bohr 52 ± 3%; Enghoff modification 67 ± 2%).
Table 1
Respiratory mechanics
Patient no.
MV days
FiO2
PaO2/FiO2 (mmHg)
PaCO2 (mmHg)
Pplateau (cmH2O)
Pdrive (cmH2O)
PL,e-i
PL,drive (cmH2O)
Crs (mL/cmH2O)
CL (mL/cmH2O)
Enghoff (%)
Bohr (%)
Position
1
7
0.50
156
87
22
8
9
5
55
82
P
2
2
0.45
208
56
24
7
17
18
54
79
S
 
3
0.55
124
57
26
8
48
66
47
S
3
0
0.50
228
44
23
9
17
16
47
62
66
56
S
4
1
0.60
123
44
71
58
P
5
0
0.40
214
48
23
13
9
9
40
54
55
42
P
 
1
0.40
278
44
18
10
7
8
50
64
48
38
P
6
1
0.45
143
49
63
40
P
7
1
0.55
183
55
23
14
11
10
36
50
60
42
P
8
1
0.40
176
52
16
8
7
5
56
95
64
51
P
9
0
0.95
98
61
29
12
14
9
38
50
P
 
5
0.60
143
89
27
12
14
9
35
45
72
60
P
10
1
0.80
125
53
21
10
11
7
36
49
66
52
P
11
2
0.55
147
49
21
12
11
10
40
51
69
47
P
12
2
0.75
113
59
25
11
11
8
26
37
69
57
P
 
3
0.65
111
47
26
12
11
8
27
40
71
60
P
13
1
0.50
192
67
24
12
10
7
47
76
82
74
P
14
6
0.70
150
62
28
15
15
11
31
43
65
52
P
Crs compliance of respiratory system, CL lung compliance, MV days days of mechanical ventilation at the time of measurement, PL,e-i end-inspiratory transpulmonary pressure, PL,drive transpulmonary driving pressure, P prone position, S supine position
Reducing PEEP resulted in an increase in lung compliance and decrease in dead space ventilation, except for patient 1 (Fig. 1).

Discussion

We demonstrate that mechanically ventilated patients with COVID-19 have a relatively high lung compliance, high dead space ventilation, and gas exchange impairment. In almost all patients, lung compliance decreased and dead space ventilation increased with increasing PEEP levels.
The decrease in lung compliance and increase in dead space ventilation in response to higher PEEP levels indicate that COVID-19 lesions were not recruited and that higher PEEP levels cause hyperinflation of the more compliant parts of the lung [1]. These results are in accordance with recent findings in COVID-19 patients [2].
When lung compliance increases in response to higher PEEP levels (patient 1), recruitment is likely and PEEP should be set accordingly [1, 2].
All patients responded extremely well to prone positioning, although the exact mechanism is unclear. Redistribution of blood flow seems to be an important mechanism.
In conclusion, we show that higher PEEP levels decrease lung compliance and in most cases increase dead space ventilation, indicating that high PEEP levels probably cause hyperinflation in patients with COVID-19. We suggest using prone position for an extended period of time (e.g., 3–5 days) and apply lower PEEP levels as much as possible.

Acknowledgements

Not applicable.
Due to standard patient care and the urgent need to gain knowledge about this new lung disease, informed consent was deemed unnecessary, but also not feasible in most cases.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020. Epub ahead of print. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020. Epub ahead of print.
2.
Zurück zum Zitat Pan C, Chen L, Lu C, Zhang W, Xia JA, Sklar MC, et al. Lung Recruitability in SARS-CoV-2 associated acute respiratory distress syndrome: a single-center, observational study. Am J Respir Crit Care Med. 2020. Epub ahead of print. Pan C, Chen L, Lu C, Zhang W, Xia JA, Sklar MC, et al. Lung Recruitability in SARS-CoV-2 associated acute respiratory distress syndrome: a single-center, observational study. Am J Respir Crit Care Med. 2020. Epub ahead of print.
3.
Zurück zum Zitat Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, et al. The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014;189(5):520–31.CrossRef Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, et al. The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014;189(5):520–31.CrossRef
4.
Zurück zum Zitat Yoshida T, Amato MBP, Grieco DL, Chen L, Lima CAS, Roldan R, et al. Esophageal manometry and regional transpulmonary pressure in lung injury. Am J Respir Crit Care Med. 2018;197(8):1018–26.CrossRef Yoshida T, Amato MBP, Grieco DL, Chen L, Lima CAS, Roldan R, et al. Esophageal manometry and regional transpulmonary pressure in lung injury. Am J Respir Crit Care Med. 2018;197(8):1018–26.CrossRef
5.
Zurück zum Zitat Doorduin J, Nollet JL, Vugts MP, Roesthuis LH, Akankan F, van der Hoeven JG, et al. Assessment of dead-space ventilation in patients with acute respiratory distress syndrome: a prospective observational study. Crit Care. 2016;20(1):121.CrossRef Doorduin J, Nollet JL, Vugts MP, Roesthuis LH, Akankan F, van der Hoeven JG, et al. Assessment of dead-space ventilation in patients with acute respiratory distress syndrome: a prospective observational study. Crit Care. 2016;20(1):121.CrossRef
Metadaten
Titel
Advanced respiratory monitoring in COVID-19 patients: use less PEEP!
verfasst von
Lisanne Roesthuis
Maarten van den Berg
Hans van der Hoeven
Publikationsdatum
18.05.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Critical Care / Ausgabe 1/2020
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-02953-z

Weitere Artikel der Ausgabe 1/2020

Critical Care 1/2020 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.